Viral hepatitis C gets personal--the value of human genomics to public health.

@article{Zhang2013ViralHC,
  title={Viral hepatitis C gets personal--the value of human genomics to public health.},
  author={L Zhang and Marta Gwinn and Dale J. Hu},
  journal={Public health genomics},
  year={2013},
  volume={16 4},
  pages={192-7}
}
About 180 million people worldwide are chronically infected with hepatitis C virus (HCV), with 3-4 million newly infected each year. Only 15-25% of acute HCV infections clear spontaneously, and the remainder persists as chronic HCV infection. More than 350,000 people die every year from hepatitis C-related liver failure and cancer. There is currently no vaccine and the standard-of-care therapies--peg-interferon alpha (pegIFN) plus ribavirin (RBV)--are expensive and have serious side effects… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 3 times over the past 90 days. VIEW TWEETS